RNASET2 as a Tumor Antagonizing Gene in a Melanoma Cancer Model-Reference-Cited by-同舟云学术

RNASET2 as a Tumor Antagonizing Gene in a Melanoma Cancer Model

Published:2008-02-01 Issue:2 Volume:17 Page:69-74
ISSN:0965-0407
Container-title:Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
language:en
Short-container-title:oncol res

Author:

Monti Laura¹,Rodolfo Monica²,Lo Russo Girieca³,Noonan Douglas³,Acquati Francesco¹,Taramelli Roberto¹

Affiliation:

1. Department of Biotechnology and Molecular Sciences, University of Insubria, Varese, Italy

2. Unit of Immunotherapy of Human Tumors, Department of Experimental Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy

3. Department of Biological and Clinical Sciences, University of Insubria, Varese, Italy

Publisher

Cognizant, LLC

Subject

Cancer Research,Oncology,General Medicine

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteome-wide Mendelian randomization identifies causal plasma proteins in lung cancer;iScience;2024-02

2. Systematic analysis of RNASET2 gene as a potential prognostic and immunological biomarker in clear cell renal cell carcinoma;BMC Cancer;2023-09-07

3. Comprehensive analysis of single-cell RNA-seq and bulk RNA-seq revealed the heterogeneity and convergence of the immune microenvironment in renal cell carcinoma;Functional & Integrative Genomics;2023-06

4. HIF2α‐induced upregulation of RNASET2 promotes triglyceride synthesis and enhances cell migration in clear cell renal cell carcinoma;FEBS Open Bio;2023-02-12

5. Systematic analysis of RNASET2 gene as a potential prognostic and immunological biomarker in clear cell renal cell carcinoma;2022-12-06